Medical Devices Startups

Albutec develops extracorporeal albumin dialysis (ECAD) technology, including its MaxiCycler device with redesigned adsorbent and tubing, to support or replace liver function in patients with acute and acute-on-chronic liver failure. The platform is intended for use by doctors, nurses, and critical care medical teams treating liver patients.

1 investor

Alcon is a global eye care company that develops and manufactures ophthalmologic products and surgical systems to improve vision. The company serves patients, surgeons, and underserved communities worldwide through product innovation, surgeon training programs, and vision screening initiatives.

1 investor

Biogen develops and markets therapies for spinal muscular atrophy (SMA), including FDA-approved treatments and the investigational ThecaFlex DRx System, an implantable intrathecal drug delivery device. The company serves patients and families affected by SMA and other neuromuscular conditions globally.

1 investor

Alere (Global Point of Care) develops portable diagnostic analyzers and blood testing systems used at the point of care by healthcare professionals. Its products, such as the i-STAT 1 Wireless, Piccolo Xpress, Afinion 2, and Cholestech LDX, provide rapid near-patient diagnostic tests including blood chemistry and lipid profiles.

1 investor

Alesi Surgical develops surgical products by combining product development expertise with commercial knowledge of surgical team needs. The company operates in the medical device sector.

1 investor

Alex Therapeutics builds clinically validated digital therapeutics and therapy companion apps that combine CBT-based interventions, consumer product design, and AI/ML to support patients managing complex conditions such as rare diseases and cancer. It works as a health technology partner for life sciences and pharmaceutical companies developing regulated digital health products.

1 investor

Algiax Pharmaceuticals is a clinical-stage biotech company developing small-molecule GABAA receptor modulators to treat neuropathic pain and other conditions with high unmet medical need. The company's lead candidate AP-325 is in Phase 2 clinical trials for chronic neuropathic pain.

1 investor

AlgoMedica develops AI-powered software for medical imaging centers to enhance CT scan quality and reduce radiation exposure. The company's PixelShine platform denoises low-dose CT scans acquired during screening programs, enabling radiologists to maintain diagnostic accuracy while supporting patients exposed to lower radiation doses.

1 investor

Algonist is a pre-clinical stage biotechnology company developing novel small molecule drugs to treat chronic pain without addiction risk. The company targets the large unmet medical need of chronic pain management, particularly in patients who fail standard analgesic treatments.

1 investor

AlgoSurg develops AI planning and automation software for surgical workflows, serving implant OEMs, robotic surgery systems, navigation platforms, and 3D printing companies. The platform automates surgical planning, segmentation, and landmarking to accelerate procedure workflows and improve accuracy.

1 investor

Aliform develops medical devices for plastic surgeons, leveraging low-risk technologies supported by preclinical evidence. The company focuses on addressing practical problems faced by plastic surgery practitioners.

1 investor

Align Technology is a medical device company that makes clear aligners (the Invisalign System) and intraoral scanners for orthodontic and restorative dental treatment. Its products are sold to orthodontists and general dentists in over 100 markets worldwide to straighten teeth and support digital dentistry workflows for patients of all ages.

1 investor

Alkermes develops pharmaceutical medicines for psychiatric and neurological disorders, including addiction, serious mental illness, and sleep disorders. The company leverages neuroscience expertise to create treatments for patients with complex conditions that are traditionally underserved.

1 investor

AiCure develops AI-powered software using computer vision and facial verification to remotely verify medication adherence and monitor patient behavior for pharmaceutical companies, biotech firms, and healthcare providers conducting clinical trials and managing chronic diseases. The platform delivers trusted patient-generated health data for clinical research, drug development, and chronic care management across regulated healthcare environments.

1 investor

Allergios develops an in-vitro allergy diagnostic that visualizes allergic responses by analyzing how a patient's blood serum induces basophil degranulation, using a disposable microfluidic chip, an optical reader (GranulEye), and AI-based analysis software. The system is aimed at clinicians for diagnosing IgE-mediated allergies, starting with food allergies as an alternative to the food challenge test.

1 investor

Allero Therapeutics is a biotech company focused on immunotherapy solutions for allergy and immune-mediated disorders, particularly Celiac Disease. The company is led by experienced pharmaceutical and biotech executives with deep expertise in immunotherapy R&D and allergen management.

1 investor

Alleye offers a smartphone-based tool for screening and monitoring retinal diseases, allowing patients and clinicians to track vision changes. It operates in the digital health space focused on ophthalmology.

1 investor

AlleyPin is a B2B medical technology provider that builds a LINE-based patient relationship management system (1.Talk) for clinics and healthcare institutions to manage patient interactions, reviews, and clinic operations. Focused on Taiwan's healthcare market, it also offers consulting services to help medical practices adopt digital tools and improve the patient experience.

1 investor

Alliance Physical Therapy Partners operates a network of outpatient physical therapy, occupational therapy, and speech therapy clinics across North America, serving patients through a therapist-led organizational model. The company also owns Work-Fit, which provides workplace health services, and Biocorrect, a custom foot orthotics manufacturer.

1 investor

Cardio Partners is a national distributor of automated external defibrillators (AEDs) and emergency preparedness solutions, offering AED sales, maintenance, CPR training, and program management services for businesses and organizations. The company serves as an American Red Cross and American Heart Association training center focused on sudden cardiac arrest prevention and bystander emergency response.

1 investor

AllMed Group designs and delivers patient-centered dialysis care and renal treatment products for patients with kidney disease. The company focuses on improving quality of life through innovative dialysis solutions.

1 investor

Alloplex Biotherapeutics develops a non-engineered autologous cellular therapy for cancer, built on its ENLYST immune cell training platform and lead candidate SUPLEXA, which trains a patient's peripheral blood cells ex vivo to create anti-tumor therapeutic cells. The company operates in the immuno-oncology and cell therapy space and has completed a Phase 1 clinical trial across multiple tumor types.

1 investor

Kalaris Therapeutics is a clinical-stage biopharmaceutical company developing retinal disease treatments, specifically engineered biologics for wet AMD, diabetic eye disease, and retinal vein occlusion. The company focuses on reducing patient treatment burden through extended-duration therapies that require fewer clinic visits.

1 investor

Allumbra combines quantum sensing technology with AI to analyze blood samples for early cancer detection. The company develops liquid biopsy tests that identify molecular signals of cancer before tumors become visible.

1 investor